Molenberghs G - Search Results

1

Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpoints.

Pryseley A, Tilahun A, Alonso A, Molenberghs G. Pryseley A, et al. Among authors: molenberghs g. Clin Trials. 2007;4(6):587-97. doi: 10.1177/1740774507084979. Clin Trials. 2007. PMID: 18042568 Review.

2

Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes.

Molenberghs G, Geys H, Buyse M. Molenberghs G, et al. Stat Med. 2001 Oct 30;20(20):3023-38. doi: 10.1002/sim.923. Stat Med. 2001. PMID: 11590630

3

Investigating the criterion validity of psychiatric symptom scales using surrogate marker validation methodology.

Alonso A, Geys H, Molenberghs G, Vangeneugden T. Alonso A, et al. Among authors: molenberghs g. J Biopharm Stat. 2002 May;12(2):161-78. doi: 10.1081/bip-120015741. J Biopharm Stat. 2002. PMID: 12413238

4

Statistical challenges in the evaluation of surrogate endpoints in randomized trials.

Molenberghs G, Buyse M, Geys H, Renard D, Burzykowski T, Alonso A. Molenberghs G, et al. Control Clin Trials. 2002 Dec;23(6):607-25. doi: 10.1016/s0197-2456(02)00236-2. Control Clin Trials. 2002. PMID: 12505240 Review.

5

A perspective on surrogate endpoints in controlled clinical trials.

Molenberghs G, Burzykowski T, Alonso A, Buyse M. Molenberghs G, et al. Stat Methods Med Res. 2004 Jun;13(3):177-206. doi: 10.1191/0962280204sm362ra. Stat Methods Med Res. 2004. PMID: 15198486

6

Modelling associations between time-to-event responses in pilot cancer clinical trials using a Plackett-Dale model.

Tibaldi F, Barbosa FT, Molenberghs G. Tibaldi F, et al. Among authors: molenberghs g. Stat Med. 2004 Jul 30;23(14):2173-86. doi: 10.1002/sim.1820. Stat Med. 2004. PMID: 15236423

7

Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints.

Alonso A, Molenberghs G, Burzykowski T, Renard D, Geys H, Shkedy Z, Tibaldi F, Abrahantes JC, Buyse M. Alonso A, et al. Among authors: molenberghs g. Biometrics. 2004 Sep;60(3):724-8. doi: 10.1111/j.0006-341X.2004.00222.x. Biometrics. 2004. PMID: 15339295

8

Validation of surrogate markers in multiple randomized clinical trials with repeated measurements: canonical correlation approach.

Alonso A, Geys H, Molenberghs G, Kenward MG, Vangeneugden T. Alonso A, et al. Among authors: molenberghs g. Biometrics. 2004 Dec;60(4):845-53. doi: 10.1111/j.0006-341X.2004.00239.x. Biometrics. 2004. PMID: 15606404

9

A unifying approach for surrogate marker validation based on Prentice's criteria.

Alonso A, Molenberghs G, Geys H, Buyse M, Vangeneugden T. Alonso A, et al. Among authors: molenberghs g. Stat Med. 2006 Jan 30;25(2):205-21. doi: 10.1002/sim.2315. Stat Med. 2006. PMID: 16220497

10

Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials.

Beunckens C, Molenberghs G, Kenward MG. Beunckens C, et al. Among authors: molenberghs g. Clin Trials. 2005;2(5):379-86. doi: 10.1191/1740774505cn119oa. Clin Trials. 2005. PMID: 16315646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters